182 related articles for article (PubMed ID: 23028521)
1. Combined, sequential intravenous and intra-arterial chemotherapy (bridge chemotherapy) for young infants with retinoblastoma.
Gobin YP; Dunkel IJ; Marr BP; Francis JH; Brodie SE; Abramson DH
PLoS One; 2012; 7(9):e44322. PubMed ID: 23028521
[TBL] [Abstract][Full Text] [Related]
2. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.
Gobin YP; Dunkel IJ; Marr BP; Brodie SE; Abramson DH
Arch Ophthalmol; 2011 Jun; 129(6):732-7. PubMed ID: 21320950
[TBL] [Abstract][Full Text] [Related]
3. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
[TBL] [Abstract][Full Text] [Related]
4. ERG monitoring of retinal function during systemic chemotherapy for retinoblastoma.
Brodie SE; Paulus YM; Patel M; Gobin YP; Dunkel IJ; Marr BP; Abramson DH
Br J Ophthalmol; 2012 Jun; 96(6):877-80. PubMed ID: 22426950
[TBL] [Abstract][Full Text] [Related]
5. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL
Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
[TBL] [Abstract][Full Text] [Related]
6. Total retinal detachments due to retinoblastoma: Outcomes following intra-arterial chemotherapy/ophthalmic artery chemosurgery.
Rowlands MA; Mondesire-Crump I; Levin A; Mauguen A; Francis JH; Dunkel IJ; Brodie SE; Gobin YP; Abramson DH
PLoS One; 2018; 13(4):e0195395. PubMed ID: 29698399
[TBL] [Abstract][Full Text] [Related]
7. Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age.
Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Xia J; Zhang J; Zhang S
BMC Cancer; 2019 Jul; 19(1):693. PubMed ID: 31307410
[TBL] [Abstract][Full Text] [Related]
8. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
[TBL] [Abstract][Full Text] [Related]
9. Intra-Arterial Chemotherapy as Primary Therapy for Retinoblastoma in Infants Less than 3 Months of Age: A Series of 10 Case-Studies.
Chen M; Zhao J; Xia J; Liu Z; Jiang H; Shen G; Li H; Jiang Y; Zhang J
PLoS One; 2016; 11(8):e0160873. PubMed ID: 27504917
[TBL] [Abstract][Full Text] [Related]
10. Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis.
Fabian ID; Stacey AW; Johnson KP; Onadim Z; Chowdhury T; Duncan C; Reddy MA; Sagoo MS
Br J Ophthalmol; 2017 Jan; 101(1):82-88. PubMed ID: 27965263
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of primarily treated group D retinoblastoma.
Kiratli H; Koç İ; Inam O; Varan A; Akyüz C
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2225-2231. PubMed ID: 29961117
[TBL] [Abstract][Full Text] [Related]
12. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
Shields CL; Manjandavida FP; Lally SE; Pieretti G; Arepalli SA; Caywood EH; Jabbour P; Shields JA
Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
[TBL] [Abstract][Full Text] [Related]
13. Evaluating primary intra-arterial chemotherapy versus intravenous plus intra-arterial chemotherapy for advanced intraocular retinoblastoma.
Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Xia J; Zhang J; Zhang S
Cancer Chemother Pharmacol; 2020 Apr; 85(4):723-730. PubMed ID: 32123960
[TBL] [Abstract][Full Text] [Related]
14. A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy.
Lambert MP; Shields C; Meadows AT
Pediatr Blood Cancer; 2008 Feb; 50(2):223-6. PubMed ID: 17278120
[TBL] [Abstract][Full Text] [Related]
15. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
16. Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes.
Say EA; Iyer PG; Hasanreisoglu M; Lally SE; Jabbour P; Shields JA; Shields CL
J AAPOS; 2016 Aug; 20(4):337-42. PubMed ID: 27328850
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.
Francis JH; Brodie SE; Marr B; Zabor EC; Mondesire-Crump I; Abramson DH
Ophthalmology; 2017 Apr; 124(4):488-495. PubMed ID: 28089679
[TBL] [Abstract][Full Text] [Related]
18. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma.
Brodie SE; Pierre Gobin Y; Dunkel IJ; Kim JW; Abramson DH
Doc Ophthalmol; 2009 Aug; 119(1):13-22. PubMed ID: 19169884
[TBL] [Abstract][Full Text] [Related]
19. Periocular carboplatin for retinoblastoma: long-term report (12 years) on efficacy and toxicity.
Marr BP; Dunkel IJ; Linker A; Abramson DH
Br J Ophthalmol; 2012 Jun; 96(6):881-3. PubMed ID: 22328819
[TBL] [Abstract][Full Text] [Related]
20. Current Treatment of Bilateral Retinoblastoma: The Impact of Intraarterial and Intravitreous Chemotherapy.
Francis JH; Roosipu N; Levin AM; Brodie SE; Dunkel IJ; Gobin YP; Abramson DH
Neoplasia; 2018 Aug; 20(8):757-763. PubMed ID: 29940303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
